A new study presents a noninvasive model for predicting clinically significant portal hypertension in patients with hepatocellular carcinoma. This tumor-adjusted approach could enhance patient management and treatment strategies.
noninvasive prediction of clinically significant portal hypertension in hepatocellular carcinoma a tumor adjusted model
Original title: “Noninvasive Prediction of Clinically Significant Portal Hypertension in Hepatocellular Carcinoma: A Tumor-Adjusted Model.”